Women who have undergone uterine artery embolization (UAE) to treat fibroids have a significantly higher risk of delivery by cesarean section as well as an increase in preterm delivery, postpartum hemorrhage, miscarriage, and lower pregnancy rates compared to the general obstetric population, according to study findings published in the November issue of the American Journal of Obstetrics and Gynecology
Women who have undergone uterine artery embolization (UAE) to treat fibroids have a significantly higher risk of delivery by cesarean section as well as an increase in preterm delivery, postpartum hemorrhage, miscarriage, and lower pregnancy rates compared to the general obstetric population, according to study findings published in the November issue of the American Journal of Obstetrics and Gynecology.
Woodruff J. Walker, FRCR, and a colleague at the Royal Surrey County Hospital in Guildford, UK, conducted a study of 56 completed pregnancies from a cohort of 1,200 women who had undergone UAE.
While 33 (58.9%) of the pregnancies were successful, six of them (18.2%) were premature and 24 (72.7%) were delivered by CD. There were 13 elective CD and nine were due to fibroids. In six cases (18.2%) there was postpartum hemorrhage. In all there were 17 (30.4%) miscarriages, three terminations, two stillbirths, and one ectopic pregnancy.
Walker WJ, McDowell SJ. Pregnancy after uterine artery embolization for leiomyomata: a series of 56 completed pregnancies. Am J Obstet Gynecol. 2006;195:1266-1271.
FDA approves updated label for Biktarvy against HIV-1
April 26th 2024Gilead Sciences has announced FDA approval of an updated Biktarvy label, showcasing safety and efficacy data from a phase 1b trial, positioning it as a pivotal treatment option for pregnant individuals with HIV-1 and suppressed viral load.
Read More
No link found between antenatal corticosteroids and child neurodevelopment
April 25th 2024A recent study found no link between antenatal corticosteroid administration and adverse neurodevelopmental outcomes in children aged 6 years or older, offering reassurance for late preterm delivery practices.
Read More
SART data indicates rise in IVF use in 2022
April 24th 2024Dive into the latest statistics from the Society for Assisted Reproductive Technology, revealing a 6% increase in in vitro fertilization cycles and a surge in egg freezing, amidst a landscape of rising fertility service demand and evolving clinical practices.
Read More